This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event
19-21 May 2026Steigenberger Icon Wiltcher's, Brussels, BE
Hybrid Event
19-21 May 2026,
Steigenberger Icon Wiltcher's, Brussels, BE

Tuesday 19 May 2026

Expert insights, actionable commercial guidance, and dynamic discussions on antitrust challenges, paired with the tools you need to navigate one of the most transformative periods for EU competitiveness and innovation

Competition and US Policy Implications in Europe | What's On?

Competition Authority and Antitrust Insights

  • Discover EU Commission antitrust enforcement updates and 2026 priorities
  • Gain insights into European Competition Authority focus and activity trends
  • Explore merger control guidelines and the impact of killer acquisitions
  • Uncover risks tied to minority interests in commercial transactions

Stay Prepared with Practical Advice

  • Master new strategies for responding to dawn raids and investigations
  • Navigate the fine line of acceptable parallel trade practices
  • Unpack the Teva Copaxone decision and its practical implications
  • Navigate antitrust risks and define boundaries for sharing sensitive information

Trump 2.0: MFN Pricing, Supply, and Tariff Implications

  • Decode the impact of MFNs and global pricing pressures on product launches
  • Explore approaches to mitigate impacts and optimize launch sequences
  • Tackle obligations to supply, parallel trade challenges, and distribution frameworks
  • Adapt to the evolving tariff landscape with actionable solutions